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INTRODUCTION
Myeloid sarcoma also known as chloroma (due to
greenish hue) or granulocytic sarcoma is a solid tumor
composed of myeloblasts and is considered an
extramedullary manifestation of Acute Myeloid Leukemia
(AML).1 Skin2 and gums3 are most frequently involved
areas and clinical manifestations mainly depend upon
the site of involvement.4,5 The use of immuno-
histochemical stains6 and flow cytometry is valuable in
the accurate diagnosis of myeloid sarcoma. As it
predicts a poor prognosis, with a poorer response to
treatment and worse survival, treatment usually is
similar to AML with consideration of local excision or
radiation whenever indicated.
We report a case of young female who presented with
lump in breast.
CASE REPORT
A 28-year old woman from Balochistan presented with
history of lump in left breast which she discovered on
self-examination. The lump was painless and static in
size over the past 2 years. She had no history of
shortness of breath, fever, bruising or bleeding from any
site. Her personal history was unremarkable. General
physical and systemic examinations did not reveal any
abnormal findings. Examination of the lump revealed an
approximately 7 x 6 cm, firm, non-tender fixed mass in
upper-outer quadrant of the breast without associated
lymphadenopathy. Ultrasound scan of the breast
showed a hypoechoic area measuring approximately
6 cm in diameter. Based on atypical examination and
ultrasound findings, excisional biopsy of the breast lump
was carried out.
Gross examination of the mass revealed nodular tissue
piece measuring 6.5 x 5.5 x 4 cm. Cut section showed a
grey-white lesion with areas of hemorrhage. Microscopic
examination of the sections showed extensive infiltration
of breast tissue by a neoplastic lesion comprising of
sheets of intermediate sized cells exhibiting scant
cytoplasm, round to oval nuclei with fine chromatin and
inconspicuous nucleoli and mitotic figures (Figure 1 A,B
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ABSTRACT
Myeloid sarcoma is a solid collection of leukemic blast cells outside bone marrow. It is seen infrequently in association
with overt Acute Myeloid Leukemia (AML), however, it invariably transforms into this aggressive condition. A 28-year
woman presented with a lump in left breast for last 2 years. Morphological and immunophenotypic results of breast mass
were consistent with myeloid sarcoma. Bone marrow aspirate and biopsy were normal, however, patient died after one
and a half years of diagnosis. Myeloid sarcoma at any extramedullary site heralds development of overt acute myeloid
leukemia and should be appropriately managed at the time of diagnosis.
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Figure 1: Haematoxylin and Eosin stained sections of breast tissue showing
infiltration by myeloid sarcoma. (A) at 20x (B, C) at 40x.
Figure 2: Immunohistochemistry on breast tissue sections. 
(A) Leucocyte common antigen. (B) Cytokeratin. (C) CD34. (D) Myeloperoxidase.
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and C). As a part of initial immunohistochemical workup,
leucocyte common antigen (Figure 2A) was positive
whereas, cytokeratin AE1/AE3 (Figure 2B) was
negative. Amongst second line immunohistochemical
stains, tumor cells showed positivity for CD34 (Figure
2C), CD117, CD43 and MPO (Figure 2D). Mib-1 (Ki-67)
was positive in approximately 30% of tumor cells.
Other haematopoietic immunohistochemical stains
including Pan B (CD20), Pan T (CD3) and terminal
deoxynucleotidyl enzyme (TdT) were negative. Bone
marrow aspirate and biopsy procedure was also
performed as a part of workup. Peripheral blood counts
including hemoglobin level (13.7 g/dl), leucocyte count
(5.4 x 109/L) with differential count and platelet count
(257 x 109/L) were within normal limits. Examination of
peripheral blood film revealed no abnormal cells and
bone marrow aspirate and biopsy showed trilineage
hematopoiesis with less than 5% blast cells and normal
cellularity for age.
Patient returned to her native area without further
medical attention. Few months later, she developed
fever, weakness, weight loss and bone pains. Patient's
family did not seek specialized medical assistance and
no further workup was carried out. However, she was
managed conservatively in her native residential area
including antipyeretics, antibiotics, intravenous fluids
and multiple blood transfusions. Almost after one and a
half years of the diagnosis of myeloid sarcoma, she
succumbed to her illness and died most likely secondary
to overt acute myeloid leukemia.
DISCUSSION
The report described a case of myeloid sarcoma
involving the breast without any evidence of bone
marrow involvement. The myeloid sarcoma is known as
primary as in this case, if it occurs in the absence of
acute or chronic myeloproliferative condition. Median
time to development of acute leukemia is 7 months
(range 1 - 25 months). However, maximum time period
of > 12 years has also been reported in the literature.7
Involvement of breast by myeloid sarcoma is usually
detected in cases without involvement of bone marrow
at the time of diagnosis.8 Whereas, concomitant
involvement of other sites in addition to breast is usually
found in cases of relapsed AML9 or progression of
chronic myeloproliferative neoplasms. This patient
belonged to a remote area of the country and she visited
the tertiary care center at the time of initial diagnosis
only. Her family did not opt for specific treatment even
when she became symptomatic. However, history of
recurrent infections, weight loss, bone pains and
multiple blood transfusions, ultimately leading to death is
an indirect evidence of development of overt acute
myeloid leukemia. Initiation of appropriate chemo-
therapeutic regimen at an earlier stage could have
saved her life.
Involvement of breast by myeloid sarcoma is a rare
entity and its detection becomes more challenging when
there is no pre- or coexisting acute or chronic
myeloproliferative neoplasm. Misdiagnosing myeloid
sarcoma as carcinoma or malignant lymphoma is a
common clinical practice error.10 A high index of
suspicion based on histological findings and a panel of
immunohistochemical stains and/or flow cytometry is
helpful in making the correct diagnosis. Prompt
treatment including surgical resection and/or radio-
therapy along with chemotherapy should be initiated at
the time of diagnosis. In this regard, appropriate
counselling of patients and their families about possible
consequences of the diagnosis is of paramount
importance.
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